AEON BIOPHARMA INC (AEON) Stock Cash Flow
NYSEARCA:AEON - NYSE Arca - US00791X2099 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 42.01M | -384.63M | -52.56M | -55.64M | 0.00 | |||
| Depreciation Amortization | 97.00K | 99.00K | 68.00K | 3.00K | 0.00 | |||
| Income Taxes - Deferred | N/A | N/A | 588.90K | N/A | 0.00 | |||
| Change In Working Capital | 706.00K | -2.74M | 6.27M | 1.42M | 1.45M | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | -63.10M | 339.45M | 10.64M | 25.79M | 0.00 | |||
| OPERATING CASH FLOW | -20.29M | -47.83M | -35.58M | -28.43M | 0.00 | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -306.00K | -170.00K | 0.00 | |||
| Other Investing Activity | N/A | N/A | 401.90K | -276.00M | -1.27M | |||
| INVESTING CASH FLOW | N/A | 0.00 | -306.00K | -170.00K | -1.27M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 15.00M | 14.00M | 40.51M | 15.00M | 25.11M | |||
| Stock Issued/Repurchased | 147.00K | N/A | 0.00 | 278.30M | 0.00 | |||
| Other Financing Activity | N/A | N/A | 0.00 | -1.44M | -540.00K | |||
| FINANCING CASH FLOW | 15.15M | 14.00M | 40.51M | 13.56M | 24.57M | |||
| CHANGE IN CASH | -5.14M | -33.83M | 4.62M | -15.04M | 0.00 | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -20.29M | -47.83M | -35.58M | -28.43M | 0.00 | |||
| Capital Expenditure | N/A | 0.00 | -306.00K | -170.00K | 0.00 | |||
| FREE CASH FLOW | -20.29M | -47.83M | -35.89M | -28.60M | 0.00 | |||
All data in USD